Abstract:Despite being considered a rare tumor, uveal melanoma (UVM) is the most common adult intraocular malignancy. With a poor prognosis and limited treatment options, up to 50% of patients develop metastases, primarily in the liver. A range of mutations and chromosomal aberrations with significant prognostic value has been associated with UVM pathogenesis. The most frequently mutated genes are GNAQ and GNA11, which encode the α subunits of Gq proteins and are described as driver mutations that activate multiple signaling cascades involved in cell growth and proliferation. Directly downstream of Gαq/11 activation, PLCβ engagement leads to sustained production of DAG and IP3. While the DAG/PKC/RasGRP3/MAPK signaling branch has been identified as an essential component of UVM unregulated proliferation, the role of IP3-mediated signals has been largely overlooked. Here, we demonstrate that, whilst maintaining Calcium homeostasis, UVM cells have developed a decoupling mechanism between IP3 and ER Calcium release by altering IP3 receptor (IP3R) expression. This correlation was observed in human UVM tumors, where IP3Rs were found to be downregulated. Critically, when IP3R3 expression was restored, UVM cells exhibited an increased tendency to undergo spontaneous cell death and became more sensitive to pro-apoptotic modulators of IP3R-mediated Calcium signaling, such as staurosporine and the Bcl2-IP3R disrupter peptide BIRD2. Finally, inhibition of the Gαq/11 signaling pathway revealed that IP3R expression is negatively regulated by GNAQ/11 oncogenic activation. Hence, we demonstrated that by remodeling IP3R expression, GNAQ/11 oncogenes protect UVM cells against IP3-triggered Calcium overload and cell death. Therefore, the GNAQ/11 pathway not only drives proliferation through DAG activity but also provides a protective mechanism to evade IP3/Calcium-mediated cell death. These dual functions could potentially be exploited in novel combinatorial therapeutic strategies to effectively block UVM cell proliferation while simultaneously sensitizing them to cell death.

Protein kinase signaling networks driven by oncogenic Gq/11 in uveal melanoma identified by phosphoproteomic and bioinformatic analyses

Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma

Supplementary Figure S1 from Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma

Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches

Comparative phosphoproteome analysis of primary and metastatic uveal melanoma cell lines

[Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches]

Uveal melanoma: molecular-genetic mechanisms of arising and the therapeutic approaches

Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma

Uveal Melanoma: Progress in Molecular Biology and Therapeutics.

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling

Gq/G11 Oncogenic Mutations Promote PD-L1 Expression and Suppress Tumor Immunity

Development of New Therapeutic Options for the Treatment of Uveal Melanoma

Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ-focal adhesion kinase signaling circuitry

Oncogenic GNAQ/11-induced remodeling of the IP3/Calcium signaling pathway protects Uveal Melanoma against Calcium-driven cell death

Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma.

Uveal melanoma: laboratory advances and new frontiers in patient care

Identifying biomarkers and novel therapeutic targets in uveal melanoma

Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations

A Platform of Synthetic Lethal Gene Interaction Networks Reveals That the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway Through FAK

Palmitoylation of GNAQ/11 is Critical for Tumor Cell Proliferation and Survival in GNAQ/11-mutant Uveal Melanoma

Expression and functional significance of phosphoenolpyruvate carboxykinase 1 in uveal melanoma